{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:35:17Z","timestamp":1794256517328,"version":"4.9.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Zoster-associated neuralgia (ZAN) is recognized as a challenging neuralgia that often leads to poor prognosis in patients receiving interventional pain management. Identifying risk factors early can enable clinicians to develop personalized treatment plans; however, research in this area is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively screened all patients with ZAN who received interventional therapy in the Pain Department of Soochow University First Affiliated Hospital from January 1, 2022 to August 31, 2023. Data on patient demographics, medical history, neutrophil-to-lymphocyte ratio (NLR), clinical scoring, and treatment methods were collected. Interventional therapy included short-term nerve electrical stimulation (st-NES), pulsed radiofrequency (PRF) and radiofrequency thermocoagulation (RF-TC). Patients were categorized into poor prognosis and control groups based on outcomes 3\u2009months post-discharge. Multivariate logistic regression was used to identify risk factors for poor prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The final analysis included 282 patients. The rate of poor prognosis was 32.6% (92\/282). Multivariate logistic regression analysis revealed that age\u2009\u2265\u200965\u2009years (odds ratio, 2.985; 95% confidence interval, 1.449\u20136.148;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), disease duration &amp;gt;3\u2009months (odds ratio, 3.135; 95% confidence interval, 1.685\u20135.832;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), head and face pain (odds ratio, 3.140; 95% confidence interval, 1.557\u20136.330;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), use of immunosuppressants (odds ratio, 2.737; 95% confidence interval, 1.168\u20136.416;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021), higher NLR (odds ratio, 1.454; 95% confidence interval, 1.233\u20131.715;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), PRF (st-NES as reference) (odds ratio, 2.324; 95% confidence interval, 1.116\u20134.844;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024) and RF-TC (st-NES as reference) (odds ratio, 5.028; 95% confidence interval, 2.139\u201311.820;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) were found to be independent risk factors for poor prognosis in patients with ZAN who underwent interventional pain management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Age\u2009\u2265\u200965\u2009years (odds ratio, 2.985; 95% confidence interval, 1.449\u20136.148;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), disease duration &amp;gt;3\u2009months (odds ratio, 3.135; 95% confidence interval, 1.685\u20135.832;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), head and face pain (odds ratio, 3.140; 95% confidence interval, 1.557\u20136.330;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), immunosuppressants use (odds ratio, 2.737; 95% confidence interval, 1.168\u20136.416;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021), higher NLR (odds ratio, 1.454; 95% confidence interval, 1.233\u20131.715;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), PRF (odds ratio, 2.324; 95% confidence interval, 1.116\u20134.844;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024) and RF-TC (odds ratio, 5.028; 95% confidence interval, 2.139\u201311.820;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) were identified as independent risk factors for poor prognosis in patients with ZAN who underwent interventional pain management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnmol.2024.1393219","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:14:56Z","timestamp":1727856896000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors for poor prognosis in patients with zoster-associated neuralgia who underwent interventional pain management"],"prefix":"10.3389","volume":"17","author":[{"given":"Junpeng","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/jcas.Jcas_45_20","article-title":"Post-herpetic neuralgia: a systematic review of current interventional pain management strategies","volume":"13","author":"Aggarwal","year":"2020","journal-title":"J Cutan Aesthet Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1056\/NEJMp058091","article-title":"Aging, immunity, and the varicella-zoster virus","volume":"352","author":"Arvin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0140-6736(06)68010-0","article-title":"Prevention and treatment of postherpetic neuralgia","volume":"367","author":"Baron","year":"2006","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1197\/aemj.10.4.390","article-title":"Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department","volume":"10","author":"Bijur","year":"2003","journal-title":"Acad. Emerg. Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.sjpain.2015.10.002","article-title":"Glial dysfunction and persistent neuropathic postsurgical pain. Scand","volume":"10","author":"Block","year":"2016","journal-title":"J. Pain"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.brainresbull.2020.04.005","article-title":"Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration","volume":"160","author":"Bombeiro","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1003993","DOI":"10.1371\/journal.ppat.1003993","article-title":"Immune suppression by neutrophils in HIV-1 infection: role of PD-L1\/PD-1 pathway","volume":"10","author":"Bowers","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/1471-2334-11-302","article-title":"Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain","volume":"11","author":"Cebrian-Cuenca","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1056171","DOI":"10.3389\/fneur.2022.1056171","article-title":"Interventions for zoster-associated pain: a retrospective study based on the clinical database","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00393-020-00915-y","article-title":"Diagnosis, treatment and prophylaxis of herpes zoster","volume":"79","author":"Ehrenstein","year":"2020","journal-title":"Z. Rheumatol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/nbdi.1998.0204","article-title":"Postherpetic neuralgia: irritable nociceptors and deafferentation","volume":"5","author":"Fields","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/j.pain.0000000000001718","article-title":"Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition","volume":"161","author":"Harvey","year":"2020","journal-title":"Pain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6015680","DOI":"10.1155\/2023\/6015680","article-title":"The effectiveness of various types of electrical stimulation of the spinal cord for chronic pain in patients with Postherpetic neuralgia: a literature review","volume":"2023","author":"Isagulyan","year":"2023","journal-title":"Pain Res. Manag."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5021\/ad.2015.27.6.771","article-title":"Do interventional pain management procedures during the acute phase of herpes zoster prevent Postherpetic neuralgia in the elderly?: a Meta-analysis of randomized controlled trials","volume":"27","author":"Jang","year":"2015","journal-title":"Ann. Dermatol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2051013615599151","article-title":"Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective","volume":"3","author":"Johnson","year":"2015","journal-title":"Ther. Adv. Vac."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang","year":"2008","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1069058","DOI":"10.3389\/fnmol.2022.1069058","article-title":"Propensity score matching comparing short-term nerve electrical stimulation to pulsed radiofrequency for herpes zoster-associated pain: a retrospective study","volume":"15","author":"Liu","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.pmrj.2014.11.009","article-title":"Treatment of postherpetic neuralgia using a thoracic transforaminal epidural steroid injection","volume":"7","author":"Mehta","year":"2015","journal-title":"PM R"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1525-1403.2009.00186.x","article-title":"Effect of temporary spinal cord stimulation on postherpetic neuralgia in the thoracic nerve area","volume":"12","author":"Moriyama","year":"2009","journal-title":"Neuromodulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1533-2500.2005.00035.x","article-title":"Postherpetic neuralgia: the never-ending challenge","volume":"5","author":"Niv","year":"2005","journal-title":"Pain Pract."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e31517","DOI":"10.1097\/MD.0000000000031517","article-title":"Comparative effectiveness of external therapies of traditional Chinese medicine and surgical treatments in pain management of postherpetic neuralgia: a protocol for a systematic review and network meta-analysis","volume":"101","author":"Pan","year":"2022","journal-title":"Medicine"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1080\/14656566.2017.1392508","article-title":"Post-herpetic neuralgia - a review of current management and future directions","volume":"18","author":"Schutzer-Weissmann","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000499471","article-title":"A high neutrophil-to-lymphocyte ratio is associated with recovery from Ramsay hunt syndrome","volume":"81","author":"Soh","year":"2019","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/photob.2019.4725","article-title":"Antimicrobial photodynamic therapy used as first choice to treat herpes zoster virus infection in younger patient: a case report","volume":"38","author":"Teitelbaum","year":"2020","journal-title":"Photobiomodul. Photomed. Laser Surg."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2147\/ijgm.S10371","article-title":"Post-herpetic neuralgia","volume":"5","author":"Tontodonati","year":"2012","journal-title":"Int. J. Gen. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/jcm9040946","article-title":"Clinical presentations and outcome studies of cranial nerve involvement in herpes zoster infection: a retrospective single-center analysis","volume":"9","author":"Tsau","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1533-2500.2010.00428.x","article-title":"Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia","volume":"11","author":"van Wijck","year":"2011","journal-title":"Pain Pract."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3959(91)90076-A","article-title":"The prognosis with postherpetic neuralgia","volume":"46","author":"Watson","year":"1991","journal-title":"Pain"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/s1386-6532(10)70005-6","article-title":"Management of herpes zoster and post-herpetic neuralgia now and in the future","volume":"48","author":"Whitley","year":"2010","journal-title":"J. Clin. Virol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1086\/342958","article-title":"Understanding pain in herpes zoster: an essential for optimizing treatment","author":"Wood","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000507859","article-title":"Red blood cell distribution width and neutrophil-to-lymphocyte ratio in predicting adverse outcomes of acute kidney injury in hospitalized patients","volume":"6","author":"Zhu","year":"2020","journal-title":"Kidney Dis."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2024.1393219\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:14:58Z","timestamp":1727856898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2024.1393219\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":37,"alternative-id":["10.3389\/fnmol.2024.1393219"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2024.1393219","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"article-number":"1393219"}}